Andon Health Co., Ltd.

Equities

002432

CNE100000Q84

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 04/07/2024 BST			5-day change	1st Jan Change
40.17 ^CNY	+1.80%		-0.91%	+6.64%

07-02	Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	CI
05-29	Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 04 June 2024	CI

Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 04 June 2024

May 29, 2024 at 08:37 pm

Andon Health Co., Ltd. announced 2023 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 3.00000000. Record date: 03 June 2024, Ex-date: 04 June 2024, Payment date: 04 June 2024.

Latest news about Andon Health Co., Ltd.

Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	07-02	CI
Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 04 June 2024	05-29	CI
Andon Health Co., Ltd. Approves Cash Dividend for 2023	05-21	CI
Andon Health's Subsidiary Gets US FDA's Nod to Market COVID-19, Influenza Test Kit	05-09	MT
Andon Health's US Unit Gets FDA Emergency Use Authorization for 3-in-1 Home Test Kits	05-08	MT
Andon Health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	04-01	CI
Andon Health Co., Ltd. announces an Equity Buyback for CNY 1,200 million worth of its shares.	02-05	CI
Andon Health Co., Ltd. authorizes a Buyback Plan.	02-04	CI
Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on August 29, 2023.	11-20	CI
Andon Health Co., Ltd.'s Equity Buyback announced on August 29, 2023, has closed with 27,164,101 shares, representing 5.77% for CNY 1,000 million.	11-16	CI
Andon Health Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	31/10/23	CI
Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on August 29, 2023.	10/10/23	CI
Andon Health Co., Ltd.(XSEC:002432) added to S&P Global BMI Index	18/09/23	CI
Andon Health Co., Ltd. announces an Equity Buyback for CNY 1,000 million worth of its shares.	29/08/23	CI
Andon Health Co., Ltd. authorizes a Buyback Plan.	28/08/23	CI
Andon Health Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25/08/23	CI
Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 13 June 2023	06/06/23	CI
Andon Health Co., Ltd. Approves Dividend for 2022	23/05/23	CI
Andon Health Co., Ltd. Proposes Final Cash Dividend for the Year 2022	04/05/23	CI
Andon Health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Andon Health Transfers Deposits in SVB to Other Banks	17/03/23	MT
Andon Health Boosts Investment Cap to 20 Billion Yuan	02/02/23	MT
Andon Health Co., Ltd. Announces Executive Changes	23/12/22	CI
Andon Health Bags US Order for COVID-19 Test Kits Worth $191 Million; Shares Jump 5%	24/11/22	MT

Chart Andon Health Co., Ltd.

Duration

Period

More charts

Company Profile

ANDON HEALTH CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of medical instruments. The Company mainly provides iHealth series products, self-owned brand products, original design manufacturer (ODM)/ original equipment manufacturer (OEM) products, mobile medical communications equipment and communications services. It distributes its products within domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/08/2024 - Q2 2024 Earnings Release

More about the company

	1st Jan change	Capi.
ANDON HEALTH CO., LTD.	+6.64%	2.56B
BIOMÉRIEUX	-6.61%	12.02B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-19.37%	6.81B
DIASORIN S.P.A.	+6.63%	5.74B
LANTHEUS HOLDINGS, INC.	+27.24%	5.47B
AUTOBIO DIAGNOSTICS CO., LTD.	-21.19%	3.59B
MYRIAD GENETICS, INC.	+30.09%	2.25B
10X GENOMICS, INC.	-66.53%	2.24B
VITROLIFE AB	-12.28%	2.21B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-21.64%	1.52B

Diagnostic & Testing Substances